Cryoglobulinemia
ICD-10 D89.1 is a billable code used to indicate a diagnosis of cryoglobulinemia.
Cryoglobulinemia is a condition characterized by the presence of cryoglobulins, which are abnormal proteins in the blood that precipitate at low temperatures. This condition can lead to various complications, primarily affecting the skin, kidneys, and nervous system. Cryoglobulinemia is often associated with underlying diseases, such as hepatitis C, autoimmune disorders, and certain malignancies. Patients may present with symptoms such as purpura, arthralgia, weakness, and renal impairment. The classification of cryoglobulinemia is typically divided into three types: type I (monoclonal), type II (mixed cryoglobulinemia associated with monoclonal and polyclonal components), and type III (polyclonal). Diagnosis is confirmed through laboratory tests that detect cryoglobulins in the serum, alongside clinical evaluation. Management may involve treating the underlying cause, immunosuppressive therapy, and plasmapheresis in severe cases. Understanding the nuances of cryoglobulinemia is crucial for accurate coding and appropriate patient management.
Detailed lab results showing cryoglobulin levels and associated symptoms.
Patients presenting with unexplained purpura or renal dysfunction.
Ensure that the type of cryoglobulinemia is clearly documented to guide treatment.
Comprehensive history of autoimmune disorders and related symptoms.
Patients with systemic lupus erythematosus or Sjögren's syndrome presenting with cryoglobulinemia.
Document any autoimmune markers and their relevance to the diagnosis.
Used to evaluate overall blood health in patients suspected of having cryoglobulinemia.
Document the reason for the CBC and any abnormal findings.
Hematologists should ensure that the CBC results are correlated with cryoglobulinemia symptoms.
Common symptoms include purpura, joint pain, weakness, and renal impairment. Symptoms can vary based on the underlying cause and type of cryoglobulinemia.
